S. Vincent Rajkumar

Active 1994–2025

477
Papers
114,462
Citations
163
h-index
463
i10-index

Citations

Citations per year for S. Vincent Rajkumar1974: 1 citations1988: 1 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 1 citations1993: 2 citations1994: 1 citations1995: 1 citations1996: 1 citations1997: 4 citations1998: 2 citations1999: 9 citations2000: 15 citations2001: 55 citations2002: 90 citations2003: 185 citations2004: 286 citations2005: 311 citations2006: 391 citations2007: 553 citations2008: 528 citations2009: 688 citations2010: 709 citations2011: 857 citations2012: 768 citations2013: 909 citations2014: 873 citations2015: 753 citations2016: 958 citations2017: 803 citations2018: 755 citations2019: 2,830 citations2020: 3,389 citations2021: 3,180 citations2022: 2,500 citations2023: 1,764 citations2024: 3,364 citations2025: 1,416 citations2026: 38 citations1975–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,730 citing papers, 27.5% of this breakdownItaly: 1,446 citing papers, 6.9% of this breakdownUnited Kingdom: 1,286 citing papers, 6.2% of this breakdownChina: 1,263 citing papers, 6.1% of this breakdownGermany: 1,243 citing papers, 6% of this breakdownFrance: 1,074 citing papers, 5.1% of this breakdownSpain: 932 citing papers, 4.5% of this breakdownCanada: 662 citing papers, 3.2% of this breakdownNetherlands: 639 citing papers, 3.1% of this breakdownAustralia: 517 citing papers, 2.5% of this breakdownGreece: 502 citing papers, 2.4% of this breakdownJapan: 439 citing papers, 2.1% of this breakdown
0%27.5%Other 24.4%

Fields

  • Medicine68.2%
  • Biochemistry, Genetics and Molecular Biology24%
  • Immunology and Microbiology3.2%
  • Computer Science1%
  • Psychology0.7%
  • Engineering0.4%
  • Other2.5%

Topics

  • Multiple Myeloma Research and Treatments16.3%
  • Protein Degradation and Inhibitors6.1%
  • Amyloidosis: Diagnosis, Treatment, Outcomes3.8%
  • Peptidase Inhibition and Analysis3.6%
  • Lymphoma Diagnosis and Treatment2.8%
  • Ubiquitin and proteasome pathways2.7%
  • Other64.7%

Coauthors

All papers

Open in search
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph D. Khoury, Hiroshi Kimura, Wolfgang Hiddemann, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William G. Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben Tooze, Alexandra Traverse‐Glehen, Francisco Vega, B. Vergier, Ashutosh Wechalekar, Brent L. Wood, Luc Xerri, Wenbin Xiao - Leukemia 2022 cited by 3,736

  2. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 cited by 2,995

  3. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 cited by 4,869

  4. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 cited by 1,506

  5. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

    Authors: - American Journal of Hematology 2022 cited by 845

  6. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Moreau - Journal of Clinical Oncology 2015 cited by 2,178

  7. Multiple myeloma

    Authors: , , , , , , , - Nature Reviews Disease Primers 2017 cited by 1,166

  8. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 1,124

  9. Prevalence of Monoclonal Gammopathy of Undetermined Significance

    Authors: , , , , , , , , - New England Journal of Medicine 2006 cited by 1,409

  10. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

    Authors: , , , , , , - New England Journal of Medicine 2018 cited by 635

  11. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 1,034

  12. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn and 30 more - The Lancet 2019 cited by 636

  13. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , - The Lancet 2016 cited by 888

  14. International uniform response criteria for multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of the International Myeloma Working Group - Leukemia 2006 cited by 2,639

  15. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

    Authors: , , , , , , , , , , , - Blood 2009 cited by 1,121

  16. Multiple myeloma current treatment algorithms

    Authors: , - Blood Cancer Journal 2020 cited by 359

  17. Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 919

  18. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Authors: , , , , , , , , , , , , - Mayo Clinic Proceedings 2003 cited by 2,431

  19. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baldeep Wirk, Matthew T. Drake, Michèle Cavo, Juan José Lahuerta, Suzanne Lentzsch - The Lancet Oncology 2019 cited by 496

  20. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    Authors: , , , , , , , , , , , , , , , - Leukemia 2013 cited by 1,396

  21. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2020 cited by 275

  22. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 cited by 191

  23. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management

    Authors: - American Journal of Hematology 2024 cited by 405

  24. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 311